Add BrightSurf on Google Email

Decoding the prognostic power of muscle strength in cirrhosis management

Research review finds handgrip strength is a reliable predictor of cirrhosis complications and outcomes, including malnutrition, muscle loss, cognitive impairment, hepatic encephalopathy, and mortality. Regular HGS assessments can inform timely personalized interventions to enhance patient quality of life.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalPortal Hypertension & Cirrhosis·TypeLiterature review·DateJul 10, 2025

AI detects fatty liver disease with chest X-rays

A research team at Osaka Metropolitan University has developed an AI model that can detect fatty liver disease from chest X-ray images with an accuracy rate of 0.82-0.83. This breakthrough has the potential to improve early detection and treatment of the disease, which affects one in four people worldwide.

SourceOsaka Metropolitan University·JournalRadiology Cardiothoracic Imaging·TypeImaging analysis·DateJun 27, 2025

Mediterranean diet provides symptom relief for patients with IBS in pilot study

A pilot study found that the Mediterranean diet provided symptom relief for patients with irritable bowel syndrome (IBS), with 73% of participants experiencing improvement. The low FODMAP diet was also effective but led to greater improvements in abdominal pain intensity and IBS severity score.

SourceMichigan Medicine - University of Michigan·JournalNeurogastroenterology & Motility·TypeRandomized controlled/clinical trial·DateMay 30, 2025

Children’s Hospital of Philadelphia researchers show stem cell transplant offers potentially curative therapy in pediatric patients with monogenic inflammatory bowel disease

A retrospective study found that allogeneic hematopoietic stem cell transplant is a highly effective method for treating children with monogenic inflammatory bowel disease, resulting in sustained medication-free remission in over 90% of patients. The treatment also led to significant improvements in growth, reduced hospital visits, and...

SourceChildren's Hospital of Philadelphia·JournalClinical Gastroenterology and Hepatology·TypeObservational study·DateMay 21, 2025

Neoadjuvant PD-1 blockade in early-stage mismatch repair-deficient cancers can eliminate the need for surgery regardless of tumor type

A phase II trial found that PD-1 blockade with dostarlimab induced complete tumor clearance and resolved the need for surgery in patients with early-stage mismatch repair-deficient cancers. This approach showed promise for preserving organs, improving quality of life, and potentially increasing survival.

Uncovering the molecular drivers of liver cancer

A study published in Journal of Proteome Research reveals that inflammation and aging contribute to the development of non-viral liver cancer. Researchers analyzed gene expression and metabolites in normal and affected samples, identifying potential therapeutic targets for chemoprevention.

SourceHiroshima University·JournalJournal of Proteome Research·DateApr 15, 2025

Research Spotlight: Comparison of single-cell profiling methods reveals strengths and limitations

The study directly compared Droplet-based scRNA (D-scRNA) and Picowell-based scRNA (P-scRNA) platforms for analyzing human mucosal biopsies. D-scRNA provides more detailed insights, but requires resources and may introduce contamination. P-scRNA is gentler, more resource-efficient, but less effective in capturing rare cell types.

SourceBrigham and Women's Hospital·JournalCellular and Molecular Gastroenterology and Hepatology·TypeObservational study·DateApr 14, 2025

AI technology for colon cancer detection shows promise for widespread use – in the future

A new clinical guideline from the American Gastroenterological Association suggests that artificial intelligence-assisted colonoscopy may improve polyp detection rates, but its impact on preventing colorectal cancer remains uncertain. The guideline recommends a cautious approach to widespread adoption, emphasizing the need for further ...

SourceAmerican Gastroenterological Association·JournalGastroenterology·DateMar 20, 2025

Impaired gastric myoelectrical rhythms associated with altered autonomic functions in patients with severe ischemic stroke

Patients with severe ischemic stroke show impaired gastric motility and autonomic dysfunction, with reduced normal gastric slow waves and increased sympathetic activity. These findings suggest a link between gastric myoelectrical rhythms and autonomic function in ischemic stroke.

SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateMar 17, 2025

Evidence-based strategies improve colonoscopy bowel preparation quality, performance, and patient experience

The updated recommendations from the US Multi-Society Task Force on Colorectal Cancer aim to achieve a benchmark of 90% exams with adequate bowel preparation. The guidelines focus on optimizing bowel preparation before, during, and after colonoscopy, including patient education, dietary restrictions, and choice of preparation agent.

Research shows blood test may provide personalized dietary therapy for patients with irritable bowel syndrome

A blood test has been found to identify personalized dietary triggers for patients with irritable bowel syndrome, resulting in improved abdominal pain relief. The study showed that 59.6% of participants who removed trigger foods experienced significant reduction in abdominal pain compared to 42.2% in the control group.

SourceMichigan Medicine - University of Michigan·JournalGastroenterology·TypeRandomized controlled/clinical trial·DateFeb 13, 2025

Fecal transplantation offers new hope for diabetes patients with severe gastrointestinal issues

A new study from Aarhus University Hospital shows that fecal microbiota transplantation can be a safe and effective treatment for patients with type 1 diabetes and gastroenteropathy. The treatment has significantly improved quality of life and symptoms for participants, offering hope to those with debilitating symptoms.

SourceAarhus University·JournalEClinicalMedicine·TypeRandomized controlled/clinical trial·DateJan 8, 2025

A simple plasma-based biomarker could predict liver fibrosis in Latino adolescents with obesity

Researchers discovered a novel combination of plasma-based biomarkers that can predict liver fibrosis in Latino adolescents with obesity. The study found that dihydroxyacetone phosphate (DHAP) and alanine transaminase (ALT) were significantly associated with fibrosis, suggesting a potential low-cost, noninvasive screening tool.

SourceChildren's Hospital Los Angeles·JournalJournal of Pediatric Gastroenterology and Nutrition·TypeExperimental study·DateDec 16, 2024

A new technology to isolate immunostimulatory members of the human gut microbiota: next-generation IgA-seq

Scientists at UMC Utrecht developed a new technology to isolate and study gut bacteria recognized by IgA antibodies, which are associated with various diseases. The next-generation IgA-SEQ method allows for high-throughput identification and analysis of these immunostimulatory bacteria, shedding light on their role in health and disease.

SourceUniversity Medical Center Utrecht·JournalMicrobiome·TypeExperimental study·DateNov 14, 2024

First steps towards national screening for Barrett's esophagus

Researchers found that using a multi-step strategy with less-invasive devices can identify patients with Barrett's oesophagus before an endoscopy. This approach is promising for cost-effective screening, which could lead to earlier diagnosis and treatment of oesophageal cancer.

SourceFlinders University·JournalJournal of Gastroenterology and Hepatology·TypeComputational simulation/modeling·DateOct 29, 2024

Chinese expert consensus on radiofrequency therapy for gastroesophageal reflux disease 2024

The 2024 Chinese consensus on radiofrequency therapy for gastroesophageal reflux disease standardizes treatment approaches by outlining essential surgical indications, contraindications, and postoperative management. The consensus also highlights the importance of precise energy application to the lower esophagus and cardia.

SourceKeAi Communications Co., Ltd.·JournalGastroenterology & Endoscopy·TypeData/statistical analysis·DateSep 20, 2024

Can’t stop belching? Dietary habits or disease could be the reason

A survey of 10,000 Japanese adults found that belching disorders are more prevalent in men who drink alcohol and take acid reflux medications. The study also identified factors such as eating until feeling full and low chewing frequency as significant contributors to the development of belching disorders.

SourceOsaka Metropolitan University·JournalThe American Journal of Gastroenterology·TypeObservational study·DateSep 3, 2024

All FODMAPs aren’t created equal: Working toward alternative diets to manage IBS

New studies suggest a simplified, less restrictive low FODMAP diet may be effective for managing irritable bowel syndrome (IBS). The alternative 'FODMAP-simple' diet restricts only fructans and galacto-oligosaccharides without restricting other FODMAP groups. This approach may reduce symptoms and improve patient adherence to the diet.

SourceMichigan Medicine - University of Michigan·JournalClinical Gastroenterology and Hepatology·TypeExperimental study·DateJul 17, 2024

Gastroenterologists generally trust and accept use of AI medical tools in clinics and hospitals, finds NTU Singapore study

A study by Nanyang Technological University found that eight in 10 gastroenterologists in the Asia-Pacific region accept and trust AI-powered tools for diagnosing colorectal polyps. The study also highlights the need for more research into what influences doctors' acceptance of AI in their medical practice.

Trust and acceptance among gastroenterologists for AI to be used in clinics and hospitals, finds NTU Singapore study

A recent NTU Singapore study found that eight in ten gastroenterologists accept and trust the use of AI-powered tools in diagnosing and assessing colorectal polyps. The study, which surveyed 165 doctors in the Asia-Pacific region, also found that more experienced gastroenterologists perceived a lower risk of AI tools.

SourceNanyang Technological University·JournalJournal of Controlled Release·DateJun 6, 2024

Brigham researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and obesity

A meta-analysis of 15 randomized studies found that patients taking GLP-1 medications experienced only mild differences in gastric emptying, delaying solid food by about 36 minutes. The findings suggest it may be safe to continue these medications before surgery without a high risk of aspiration.

SourceBrigham and Women's Hospital·JournalThe American Journal of Gastroenterology·TypeRandomized controlled/clinical trial·DateJun 4, 2024